Transtrochanteric fractures: Postoperative use of alendronate

Acta Ortopedica Brasileira

Volumn 19, Issue 1, 2011, Pages 45-48

  Cardoso, Francisco José Nunes ^a   Nakano, Augusto Sadao ^a   Frisene, Marcel ^a   Hereda, Manoel Emilio de Freitas ^a   Batista, Bruno de Faria ^a   Kanaji, Paulo Rogério Cardozo ^a  

^a HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

Author keywords

Alendronate sodium; Consolidation; Osteoporosis; Post surgery. Transtrochanteric femoral fracture; Radiography

Indexed keywords

EID: 79955430095     PISSN: 14137852     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-78522011000100010     Document Type: Article

References (18)

1. DeLee JC. Fractures and dislocations of the hip in fractures in adults. In: Rockwood CA Jr, Green DP, editors. Philadelphia: J.B. Lippincott; 1984. p. 1211-356.
2. Ramalho AC, Lazaretti-Castro M, Hauache O, Vieira JG, Takata E, Cafalli F et al. Osteoporotic fractures of proximal femur: clinical and epidemiological features in a population of the city of São Paulo. Sao Paulo Med J. 2001;119:48-53.
3. Röder F, Schwab M, Aleker T, Mörike K, Thon KP, Klotz U. Proximal femur fracture in older patients - rehabilitation and clinical outcome. Age Ageing. 2003;32:74-89.
4. Stolnicki B, Aronson D. Avaliação densitometria em portadores de fraturas osteoporóticas. Rev Bras Ortop. 1993;28:304-8.
5. Iida Y, Kuroda T, Kitano T, Mizuno K. Dexa-measured bone density changes over time after intertrochanteric hip fractures. Kobe J Med Sci. 2000;46: 1-12.
6. Tronzo RG. Special considerations in management. Orthop Clin North Am 5: 571-583, 1974.
7. Koberle G. Fraturas transtrocanterianas. Rev Bras Ortop. 2001;36:325-9.
8. Guarnieiro R, Oliveira LG. Osteoporose: atualização no diagnóstico e princípios básicos para o tratamento. Rev Bras Ortop. 2004;39:477-85.
9. Pinto Neto AM, Soares A, Urbanetz AA, Souza AC, Ferrari AE, Amaral B et al. Consenso Brasileiro de Osteoporose 2002. Rev Bras Reumatol. 2002;42:343-54.
10. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999;282:1344-52.
11. Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML et al. Randomized trial of the effects of risedronate on fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int. 2000;11:83-91.
12. Riggis BL, Melton LJ 3rd. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 1995;17(5 Suppl):505S-11S.
13. Lu Y, Genant HK, Shepherd J, Zhao S, Mathur A, Fuerst TP et al. Classification of osteoporosis based on bone mineral densities. J Bone Miner Res. 2001;16: 901-10.
14. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC et al. Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348:1535-41.
15. Huddleston JM, Whitford KJ. Medical care of elderly patients with hip fractures. Mayo Clin Proc. 2001;76:295-8.
16. Canto RST, Luciano RC, Souza MR, Ilton J, Martins AP. Uso do DHS no tratamento das fraturas intertrocantéricas. Rev Bras Ortop. 1996;31:1007-12.
17. Cunha U, Veado MA. Fratura da extremidade proximal do fêmur em idoso: independência funcional e mortalidade em um ano. Rev Bras Ortop. 2006;41:195-9.
18. Polesello GC, Honda EK, Ono NK, Guimarães RP, Oliveira LA, Boulos-Dumans M et al. Artroscopia do quadril: experiência após seguimento médio de 33 meses. Rev Bras Ortop. 2006;41:145-50.